 CHATHAM, N.J., April 25, 2022 GLOBE NEWSWIRE -- Tonix Pharmaceuticals Holding Corp. Nasdaq: TNXP, a clinical-stage biopharmaceutical company, announced today that Seth Lederman, President and Chief Executive Officer of Tonix Pharmaceuticals, will present at B. Riley Securities 2022 Virtual Neuro Ophthalmology Conference on Wednesday, April 27, 2022, at 1:00 p.m.ET. 